---
schema_version: "secwatch.filing_event.v1"
accession: "0001609550-25-000055"
form_type: "8-K"
ticker: "INSP"
cik: "0001609550"
company_name: "Inspire Medical Systems, Inc."
filed_at: "2025-11-17T23:59:59+00:00"
generated_at: "2026-05-16T19:17:00.759326+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Inspire Medical Systems expects $90M-$100M tax benefit from valuation allowance release

## Summary
- Company disclosed expectation to release a significant portion of valuation allowance on U.S. deferred tax assets.
- Estimated income tax benefit of $90 million to $100 million for fiscal year 2025.
- Diluted earnings per share expected to increase by approximately $3.00 to $3.30.
- Disclosure made on November 6, 2025, and filed on November 17, 2025.
- The benefit will be recorded in the fourth quarter of fiscal 2025.

## SEC filing metadata
- accession: 0001609550-25-000055
- form_type: 8-K
- ticker: INSP
- cik: 0001609550
- company_name: Inspire Medical Systems, Inc.
- filed_at: 2025-11-17T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609550/000160955025000055/0001609550-25-000055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609550/000160955025000055/insp-20251117.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001609550-25-000055
- JSON: https://secwatch.observer/filing/0001609550-25-000055.json
- Plain text: https://secwatch.observer/filing/0001609550-25-000055.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.